Memantine and Validation of a New Alzheimer's Disease Scale

Clinical trial NCT00804271 · COMPLETED

Trial details

NCT number: NCT00804271
Sponsor: Merz Pharmaceuticals GmbH
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2008-12-01
Primary completion: 2009-11-01
Enrollment: 487

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.